Frequency Therapeutics (FREQ) Financials

$0.30

$-13.84 (-97.88%)

As on 03-Nov-2023 16:00EDT

Market cap

$11 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	14.07	36.98	28.95	--
Cost of Revenue	--	--	--	--	16.00	--
Gross Profit	--	--	14.07	36.98	28.95	--
Operating Expenses	63.20	83.00	98.10	64.53	49.62	18.94
Operating Profit (EBIT)	-63.20	-83.00	-84.03	-27.55	-20.68	-18.94
Other Income	--	--	--	0.99	--	--
Profit before Tax	-59.29	-81.58	-84.67	-26.48	-18.75	-19.17
Provision for Tax	0.03	0.00	0.02	0.04	-2.74	-0.12
Profit after Tax (Net Income)	-59.32	-81.58	-84.69	-26.51	-16.00	-19.17
Minority Interest	--	--	--	--	--	3.77
Consolidated Profit	--	--	-84.69	-26.51	-19.80	-19.17

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	36.74	-261.67	130.82	-95.40	-68.89	-48.28
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	31.02	43.11	45.60	3.08	89.06
Current Liabilities	9.61	21.03	11.43	26.63	52.78	3.77
Total Liabilities	55.96	121.24	185.36	264.72	223.22	44.55

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	3.85	33.75	50.61	39.66	1.86	1.61
Current Assets	42.50	87.49	134.75	225.06	221.36	42.94
Total Assets	88.85	-209.62	185.36	-23.17	-13.03	44.55
Total Debt*	1.43	42.95	45.60	45.99	--	--
Net Current Assets	--	66.47	123.32	198.43	168.58	39.16

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-58.24	-76.06	-45.19	34.22	-17.02
Cash Flow from Investing Activities	--	--	-66.13	10.40	-18.26	-0.44
Cash from Financing Activities	--	-0.58	1.36	56.69	142.02	41.71
Net Cash Inflow / Outflow	--	--	--	21.90	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.66	-2.31	-2.45	-0.78	-0.56	-1.06
Cash EPS ($)	--	-2.24	-2.37	-0.75	-0.53	-1.02
Adjusted Book Value ($)	--	--	3.78	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.65	-2.20	-1.34	1.20	-0.94
Free Cash Flow per Share ($)	--	-1.65	-2.28	-1.53	1.17	-0.96

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	385.78	-133.35	44.82	27.32	49.20
ROE (%)	-131.83	124.70	-478.11	32.27	27.32	49.20
ROA (%)	-48.45	-53.22	-37.63	-10.87	-11.95	-59.59
EBIT Margin (%)	--	--	-597.32	-74.49	-71.42	--
Net Margin (%)	--	--	-601.98	-69.81	-55.29	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	-1.00	-0.62	0.28	--	--
EBIT Growth (%)	42.53	1.22	-205.01	-33.25	-9.14	-50.96
Net Profit Growth (%)	30.80	3.67	-219.44	-65.65	16.51	5.28
EPS Growth (%)	32.35	0.05	-2.12	-0.39	0.47	--
Book Value Growth (%)	-57.22	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-1.66	-2.10	-44.96	-31.12	--
Price / Book Value	0.91	-0.52	1.36	-12.50	-7.23	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.24	-0.80	-1.14	-36.83	-12.65	--
Close Price ($)	18.50	192.50	256.50	1,763.00	876.50	--
High Price ($)	279.50	289.50	2,918.50	2,144.55	1,024.50	--
Low Price ($)	16.29	50.00	234.00	725.00	558.50	--
Market Cap ($ Cr)	10.94	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.16	0.35	-0.48	--	--
Short term debt to equity ratio	0.04	-0.05	0.02	0.00	-0.05	--
Current Ratio	4.42	4.16	11.79	8.45	4.19	11.38
Quick Ratio	4.42	3.99	11.47	8.29	4.14	--
Interest Coverage	-98.47	-86.37	-109.99	-11.98	-11.59	-178.72

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	1.02	0.92	2.78	--
Asset Turnover	--	--	0.06	0.15	0.22	--
Receivable days	--	--	6.28	5.65	6.09	--
Inventory Days	--	--	--	--	68.39	--
Payable days	--	--	--	--	35.18	--
Cash Conversion Cycle	--	--	--	--	39.31	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.